• 177Lu radiolabeled peptides for breast cancer therapy [abstract] 

    Calzada, Victoria; Zhang, Xiuli; Cabral, Pablo; Fernandez, Marcelo; Gambini, Juan Pablo (2010-11)
    ErbB-2 is a type 1 receptor tyrosine kinase over-expressed on ~30% of breast cancers and is an attractive target for the development of new diagnostic and therapeutic agents. The ErbB-2 avid peptide KCCYSL, originally ...
  • Evaluation of [99MTc]glucarate as a breast cancer imaging agent: bench to bedside [abstract] 

    Zhang, Xiuli; Gambini, Juan Pablo; Cabral, Pablo; Figueroa, Said Daibes; Ma, Lixin; Savio, Eduardo; Deutscher, Susan L.; Alonso, Omar (2010-11)
    The use of [99mTc]glucarate has been reported as an infarct-avid agent with the potential for very early detection of myocardial infarction. [99mTc]glucarate has also been postulated as an agent for non-invasive detection ...
  • Identification of novel breast carcinoma and melanoma avid peptides for imaging 

    Jin, Xiaofang (University of Missouri--Columbia, 2009)
    During the last decade, peptides and their derivatives have been employed as effective cancer imaging agents. We aimed to identify new peptides probes specific for melanoma and breast carcinoma by phage display technology. ...